Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Parkinson’s Disease is a chronic and progressive disease of the nervoussystem and it became worse over time. It is the second most common neurologicaldisorder. In ordinary Conditions, nerve cells exhibit in cerebrum and deliversa neurotransmitter called dopamine that oversees a development, feelings, andco-appointment yet because of unhealthy individual dopamine creation, hence theindividual end up with control the development ordinarily. In Germany, has alifetime prevalence of between 0.1 and 0.3% of the population.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society ofIndia; Australian Parkinson’s DiseaseSociety; Movement Disorder Society ofJapan
Parkinson’s is one of the well-known age connected neurodegenerative disorder, in return simply to Alzheimer's disease. There areapproximately seven Million individuals affected with Parkinson’s globally.Several studies and theories are considering the danger factors and theprotecting measures for the onset of the Parkinson, though the results wereimperfect and foreseeable. The neuroepidemiology of PD is very complex withsusceptibility genes and several modifiable risk factors that can increase andothers that can mitigate risks and outcomes.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society ofIndia; Australian Parkinson’s DiseaseSociety; Movement Disorder Society ofJapan
The identification of PD is difficult in earlier stages, it goes on atthe end the result is not obtained. There is no direct treatment for PD andthere is no biopsy reports or scan reports that confirm the diagnosis. Atpresent, there is no cure for PD. Medication is given in 3 stages: Initialstage includes the drug called Levodopa, which increase the monoamineneurotransmitter in the brain, the second stage shows less severe PD symptomsand the third stage will help to manage the non-motor symptoms as well asdepression. Magnetic Resonance Imaging and Computed Tomogram are used by manyphysicians to find out other relating Parkinson’s diseases such asencephalitis, Tumours, Hydrocephalus. Dopamine level release and activity ofthe brain can easily detect using PET and SPECT examining.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society ofIndia; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
The introduction about Levodopa and the demonstration that dopamine loss is the key pathological feature of PD have revolutionized the field of PD therapeutics. In most cases of Parkinson’s disease, protein deposits called Lewy Bodies. It is unclear whether Lewy bodies play an important role in killing nerve cells or just part of the cells which are responsible to the Parkinson’s disease. Nearly 15 percent of people with PD have motor symptoms that are not controlled with levodopa. A group of drugs that act directly on dopaminergic reports called dopamine against is used as adjuncts to levodopa in the treatment of PD.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
Parkinson’s disease is not a life-threatening condition. With time, the illness will bring more problems with speech, movement, and brain functioning. Parkinson’s disease is usually accompanied by additional problems, which may be cured, and they are thinking difficulties, swallowing, depression and emotional changes, sleep difficulties, constipation, blood pressure changes, fatigue, pain, and some complications are Insomnia, Urinary Incontinence, Paraesthesia.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society ofIndia; Australian Parkinson’s DiseaseSociety; Movement Disorder Society ofJapan
Parkinson’s disease is originated from the gradual loss of cells in the substantia nigral of the brain. This is mainly responsible for the assembly of neuro transmitter. Dopamine is a neurotransmitter which transmits signals between two regions of the brain to coordinate activities like the movement oflimbs. If there is a deficiency in dopamine production results in loss of coordination and end up with the symptoms of Parkinson’s Disease. The disease progresses, various areas of the brain and nervous system degenerate to boo inflicting a lot of movement disorder.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25,2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
To develop a drug or treatment for Parkinson’s disease observational study is being conducted by a scientist in a laboratory to provide patients with a better life. Clinical trials are performed to slow down the rate of suffering and reduce the symptoms. There is no cure for PD as far, butresearchers improved more treatment. Trails help to reduce the risk factors. Trail sari the best way to find out whether a new treatment is safe, is a benefit to patients, is more effective, is that improving the quality of life with PD
Clinical research is an expensive process which requires strong financial support. This comes from a range of sponsors including thepharmaceutical industries, Governments, Researchers, and Organizations.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
Free radicles have both beneficial and baleful effect on human body parts. Oxidative stress is known to cause many neurological disorders such as Alzheimer’s, Parkinson’s and Amyotrophic Lateral Sclerosis. With oldness, there is a typical failure of the dopamine-producing neurons. In some of the rare situation’s symptoms are seen in children and terms is referred to as Juvenile Parkinsonism.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
It is important to develop a PD management plan because it is a chronic disease. The individual should get practiced maintaining the stress levels and depression by daily communicating with close people, friends, colleagues. Patients can improve life by following Instructions given by the counsellor. Managing life with PD includes building a healthcare team with proper Doctors, proper intake of medications, exercises, nutritional drink, and proper sleep.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
Risk factors for the PD mainly depend on age, hereditary, sex and exposure to toxins. The causes of the diseases are believed to be either genetic or environmental. Symptoms and progression of disease will not be the same among the suffering individuals but people with Parkinson’s are at higher rate of developing related risks. Parkinson’s disease has a chance of creating mental ailment which can be mild or serious. It includes cognition, mood, behavior which are considered as major impairment when compared to normal populational. The common mood swings seen in the patients are despair, eagerness, indifference Melanoma, Neurogenic, Orthostatic Hypotension, Executive dysfunction, Orthostatic hypertension. Now a day’s Head Injury and Gene variation are in addition to an element of PD.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
Neurodegeneration is the progressive loss of structure or function of neurons, including the death of neurons. Many neurodegenerative diseases –including Parkinson's disease, Alzheimer's disease, and Huntington's disease and amyotrophic lateral sclerosis, – occur as a result of neurodegenerative processes. The greatest risk factor for neurodegenerative diseases is aging. Mitochondrial DNA mutations as well as oxidative stress both contribute to aging. Many of these diseases are late onset, meaning there is some factor that changes as a person ages for each disease. One constant factories that in each disease, neurons gradually lose function as the disease progresses with age. It has been proposed that DNA damage accumulation provides the underlying causative link between aging and neurodegenerative disease.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
Huntington’s disease (HD) is a fatal genetic disorder usually inherited from Parents and often many describe the symptoms of HD as having Parkinson’s and Alzheimer’s disease simultaneously. Symptoms usually appear between the ages of 30 to 50 and worsen over a 10 to 25 every year. The weak people tend to have pneumonia, Heart failure, and other complications. Every person who inherits the expanded HD gene will eventually develop the Huntington disease. Over a period, HD affects the individual’s ability to reason, walk and speak. In approximately 10% of cases have HD in children or adolescents. The symptoms of Juvenile HD are somewhat different than adult-onset HD and it includes Stiffness or awkward walking, increased clumsiness and changes in speech. The ability of learning skills may tend to decline, and the child may lose skills.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
According to studies more than men, women were mostly affected by Bradykinesia. It is a reduced pace in bodily movements of a person. Parkinson’s has four key symptoms, in that Bradykinesia is one among them. Parkinson’s is also called "Idiopathic parkinsonism", meaning parkinsonism with nonidentifiable cause.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
Ataxia is a degenerative disease of the nervous system. Many symptoms of Ataxia can mimic those of being drunk - slurred speech, stumbling, falling, and incoordination. All are related to degeneration of the part of the brain ,called the cerebellum that is responsible for coordinating movement. Ataxia isa disease that affects people of all ages. Age of symptom-onset canary widely, from childhood to late adulthood. Complications from the disease are serious, oftentimes debilitating, and can be life-shortening. Ataxia is anumbrella term used to classify a group of diseases that include: Ataxia Telangiectasia, Episodic Ataxia, Friedreich’s Ataxia, Multiple System Atrophy, Spinocerebellar Ataxia, Sporadic Ataxia.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
Aphasia is an inability to comprehend or formulate language because of damage to specific brain regions. This damage is typically caused by cerebral vascular accident (stroke), or head trauma; however, these are not the only possible causes. In Aphasia, a person's speech or language will be significantly impaired in one (or several) of the four communication modalities following acquired by brain injury or have significant decline over a short time period. The four communication modalities are auditory comprehension, verbal expression, reading and writing, and functional communication.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congress on Parkinson's and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
